首页|富血小板血浆治疗膝骨关节炎的临床疗效与其生物学特性的关系

富血小板血浆治疗膝骨关节炎的临床疗效与其生物学特性的关系

扫码查看
目的 探讨关节腔内注射富血小板血浆(PRP)治疗膝骨关节炎患者的临床疗效,并分析其与PRP生物学特性的关系.方法 110例膝骨关节炎患者随机均分为PRP组和透明质酸(HA)组,分别接受关节腔内单次PRP和HA注射治疗.评估两组治疗前和治疗6周、3个月和6个月时国际膝关节文献委员会(IKDC)主观评分、VAS疼痛评分和西安大略麦克马斯特大学骨关节炎指数(WOMAC)评分,并观察治疗前后不良事件的发生情况.检测PRP中细胞计数、生长因子和细胞因子水平,分析其与临床结局的关系.结果 与治疗前相比,两组治疗后IKDC主观评分、VAS疼痛评分、WOMAC各项评分及总分均改善(P<0.05);PRP组治疗6个月时IKDC主观评分高于HA组(P<0.05);PRP组治疗6周时WOMAC功能、僵硬评分及总分低于HA组(P<0.05).PRP组VAS疼痛评分高于最小临床重要差异(MCID)患者的血小板源性生长因子-BB(PDGF-BB)和PDGF-AB水平高于VAS疼痛评分低于MCID患者(P<0.05).两组不良事件发生率比较无统计学差异(P>0.05).结论 关节腔内注射PRP对膝骨关节炎患者有显著的临床疗效,患者满意度和安全性较高.PRP治疗膝骨关节炎时需要考虑生长因子的水平.
Relationship between clinical efficacy and biological characteristics of platelet rich plasma in the treatment of knee osteoarthritis
Objective To investigate the clinical efficacy of intra-articular injection of platelet rich plasma(PRP)in the treatment of the patients with knee osteoarthritis,and analyze the relationship between the clinical efficacy and biological characteristics of PRP.Methods A total of 110 patients with knee osteoarthritis were equally randomized into two groups of PRP and HA,who accepted intra-articular injection of single PRP and hyaluronic acid,respectively.The International Knee Documentation Committee(IKDC)subjective score,VAS pain score and Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC)score were evaluated before treatment and in the 6th week,3rd month and 6th month after treatment.The incidence of adverse events before and after treatment was observed.The cell counts,growth factor and cytokines levels in group PRP were detected for analyzing their relationship with the clinical outcomes.Results Compared with before treatment,the IKDC subjective score,VAS pain score,and WOMAC each item and total scores were improved after treatment in both groups(P<0.05).The IKDC subjective score in the 6th month after treatment in group PRP was higher than that in group HA(P<0.05).The function,stiffness and total scores of WOMAC in the 6th week after treatment in group PRP were lower than those in group HA(P<0.05).The levels of platelet-derived growth factor-BB(PDGF-BB)and PDGF-AB in the patients with VAS pain score more than the minimal clinically important difference(MCID)were higher than those in the patients with VAS pain score less than MCID in group PRP(P<0.05).There was no statistical difference in the incidence of adverse events between the two groups(P>0.05).Conclusion The intra-articular injection of PRP has an obvious clinical effect on knee osteoarthritis with higher patients'satisfaction and safety.The levels of growth factors should be considered during the treatment of knee osteoarthritis with PRP.

Knee osteoarthritisPlatelet rich plasmaGrowth factorCytokines

桂忠山、宁显宗、朱亮亮、王桂华、周斌、王北岳

展开 >

211800 江苏,南京市浦口人民医院骨科

膝骨关节炎 富血小板血浆 生长因子 细胞因子

2024

江苏医药
江苏省人民医院(南京医科大学第一附属医院)

江苏医药

影响因子:0.707
ISSN:0253-3685
年,卷(期):2024.50(12)